Evidence map›Paper›PMID 26483877›Full record

ReviewWorld journal of gastrointestinal oncology2015

Relationship between intestinal microbiota and colorectal cancer.

Gokhan Cipe, Ufuk Oguz Idiz, Deniz Firat, Huseyin Bektasoglu

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastrointestinal oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. MOF-Ag Nanozyme forInternational journal of nanomedicine · 2026
    Article
  5. Review
  6. Outer Membrane Vesicles FromJournal of extracellular biology · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Gut microbiota-derived metabolites in CRC progression and causation.Journal of cancer research and clinical oncology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Gokhan CipeGokhan Cipe, Department of General Surgery, Fatih University, Istanbul 34844, Turkey.
Ufuk Oguz IdizGokhan Cipe, Department of General Surgery, Fatih University, Istanbul 34844, Turkey.
Deniz FiratGokhan Cipe, Department of General Surgery, Fatih University, Istanbul 34844, Turkey.
Huseyin BektasogluGokhan Cipe, Department of General Surgery, Fatih University, Istanbul 34844, Turkey.
Fatih University · TRBezmiâlem Vakıf Üniversitesi · TRCreative Research Enterprises (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human gastrointestinal tract hosts a complex and vast microbial community with up to 10(11)-10(12) microorganisms colonizing the colon. The gut microbiota has a serious effect on homeostasis and pathogenesis through a number of mechanisms. In recent years, the relationship between the intestinal microbiota and sporadic colorectal cancer has attracted much scientific interest. Mechanisms underlying colonic carcinogenesis include the conversion of procarcinogenic diet-related factors to carcinogens and the stimulation of procarcinogenic signaling pathways in luminal epithelial cells. Understanding each of these mechanisms will facilitate future studies, leading to the development of novel strategies for the diagnosis, treatment, and prevention of colorectal cancer. In this review, we discuss the relationship between colorectal cancer and the intestinal microbiota.

Indexed as

CancerColorectalIntestinalMicrobiotaSporadic

Identifiers

PMID26483877
PMCPMC4606177
OpenAlexW2337367722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.